FDA Approved: PREGABALIN — Supplemental Application (Cipla USA, Inc.)

View source ↗

Summary

The FDA approved Cipla's supplemental application to market a generic pregabalin product, enabling a generic version of the drug for its approved indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy
• Epilepsy
• Fibromyalgia
• Generalized Anxiety Disorder
• Spinal Cord Injury

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

SUPPL AP for PREGABALIN (PREGABALIN)